background preloader

Patents: privatizing acad: knwdg squeezing out public knowldge

Facebook Twitter

An Error Occurred Setting Your User Cookie. Bayh–Dole Act. The Bayh–Dole Act or Patent and Trademark Law Amendments Act (Pub. L. 96-517, December 12, 1980) is United States legislation dealing with intellectual property arising from federal government-funded research. Sponsored by two senators, Birch Bayh of Indiana and Bob Dole of Kansas, the Act was adopted in 1980, is codified at 94 Stat. 3015, and in 35 U.S.C. § 200-212,[1] and is implemented by 37 C.F.R. 401.[2] The key change made by Bayh-Dole was in ownership of inventions made with federal funding. Before the Bayh–Dole Act, federal research funding contracts and grants obligated inventors (where ever they worked) to assign inventions they made using federal funding to the federal government.[3] Bayh-Dole permits a university, small business, or non-profit institution to elect to pursue ownership of an invention in preference to the government.[4] History[edit] Recipient requirements[edit] Certain additional requirements apply to nonprofit organizations only.

Subject inventions[edit] Patent. A patent (/ˈpætənt/ or /ˈpeɪtənt/) is a set of exclusive rights granted by a sovereign state to an inventor or assignee for a limited period of time in exchange for detailed public disclosure of an invention. An invention is a solution to a specific technological problem and is a product or a process.[1]:17 Patents are a form of intellectual property. Under the World Trade Organization's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights, patents should be available in WTO member states for any invention, in all fields of technology,[3] and the term of protection available should be a minimum of twenty years.[4] Nevertheless, there are variations on what is patentable subject matter from country to country. Definition[edit] The word patent originates from the Latin patere, which means "to lay open" (i.e., to make available for public inspection).

History[edit] U.S. patents granted, 1790–2010.[11] Law[edit] Effects[edit] Enforcement[edit] Ownership[edit] Review: “How Economics Shapes Science,” by Paula Stephan. "How Economics Shapes Science" I recently finished a very interesting and useful book entitled, “How Economics Shapes Science,” written by the economist Paula Stephan (Professor of Economics, Georgia State University and a member of the National Bureau of Economic Research).

Stephan is an economist who accidentally became an expert in science economics, a little vignette that sets a nice tone for the book, which is superb overall — well-written, smartly structured, and well-referenced. In fact, for the serious reader, I’d recommend ordering it in print because the ability to flip back and forth between the nicely designed and very usable notes pages and the main text is vital to enjoying the book. While the topic is of inherent interest to anyone working in the sciences, Stephan also touches on many points of particular interest to publishers, including why authors publish and related issues. (Editor’s note: An interview with the author was published with this review.) Like this: Gene cartels: biotech patents in the age of free trade - Luigi Palombi. Monsanto. Quebec's 'truncheon law' rebounds as student strike spreads | Martin Lukacs.

At a tiny church tucked away in a working-class neighbourhood in Montreal's east end, Quebec's new outlaws gathered on Sunday for a day of deliberations. Aged mostly between 18 and 22, their membership in a progressive student union has made them a target of government scorn and scrutiny. And they have been branded a menace to society because of their weapons: ideas of social justice and equal opportunity in education, alongside the ability to persuade hundreds of thousands to join them in the streets. Under a draconian law passed by the Quebec government on Friday, their very meeting could be considered a criminal act. Law 78 – unprecedented in recent Canadian history – is the latest, most desperate manoeuvre of a provincial government that is afraid it has lost control over a conflict that began as a student strike against tuition hikes but has since spread into a protest movement with wide-ranging social and environmental demands.

All this is said with a straight face. Public-Private Partnerships: Goods and the Structure of Contracts - Annual Review of Resource Economics, 1(1):75. EU-wide patent regime at hand. 10 december 2012 - Patenting in the EU is four times more expensive than in other developed economies, but after more than 30 years, a new agreement is at hand. The new regime will protect inventions better, will cut costs up to 80 percent and boosts the competitiveness of small and medium-sized enterprises. The idea of a unitary patent valid throughout the EEC was already being aired at its foundation in 1957.

However, an agreement was never put into force. The European patent with unitary effect relies upon three separate pieces of legislation implemented via three different procedures. Champion of expensive patenting A very important aspect of the unitary patent is the reduction of costs, which will improve the competitive position of EU firms since in US and Japan patents are much cheaper. The new patent regime will be put into force on 1 January 2014 or when more than 13 countries ratify it, provided that the UK, France and Germany are among them. In Standing Up for Big Ag, Are Universities Undercutting Their Own Researchers? - Bottom Line.

In a case before the U.S. Supreme Court this month, advocates for academic researchers are urging the justices to reverse a patent-infringement decision that has given the Monsanto Company broad authority to restrict scientists’ study of genetically modified seeds. The decision, the advocates say, not only hurts farmers and fuels higher food prices; it also contributes to “the suffocation of independent scientific inquiry into transgenic crops.”

Not surprisingly, the case has also drawn the attention of higher education’s research establishment—but it’s pulling for the other side. The friend-of-the-court brief that advocates for the academic scientists comes from two nonprofit organizations, the Center for Food Safety and Save Our Seeds. It describes professors at two universities who were forced to abandon their research on sugar beets grown from Monsanto’s patented Roundup Ready transgenic seeds, because the company insisted on the right to block publication of their findings. Mr. @timoreilly This paper on abolishing the patent system, by two Fed economists, is truly remarkable in its comprehensive insight. This site uses cookies to improve performance. If your browser does not accept cookies, you cannot view this site.

Setting Your Browser to Accept Cookies There are many reasons why a cookie could not be set correctly. Below are the most common reasons: You have cookies disabled in your browser. You need to reset your browser to accept cookies or to ask you if you want to accept cookies. Why Does this Site Require Cookies? This site uses cookies to improve performance by remembering that you are logged in when you go from page to page. What Gets Stored in a Cookie? This site stores nothing other than an automatically generated session ID in the cookie; no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. Woede om patent genetisch gemanipuleerde aap - Nieuws.

Fast Track Competition | GlaxoSmithKline. UCLA tells professors not to apply for major new pharmaceutical grant. These days many research universities are constantly looking for new grant competitions and encouraging their faculty members to apply. On Friday, the University of California at Los Angeles took the unusual step of telling professors not to apply to a major new grant competition from a pharmaceutical company, saying that the program violated university rules. An e-mail marked "urgent" was sent Friday to all faculty members and deans about the Discovery Fast Track Competition, which was just announced this month and for which the sponsor -- GlaxoSmithKline -- is approaching faculty members directly, bypassing technology transfer offices at universities.

The company announced that the program was an attempt to reward academic researchers by offering a "fast track" to financing their most creative ideas. Faculty members are invited to submit short proposals and promised a quick decision later this year, leading to funding. "This is a challenging situation for us," he said. From Novel Research to Innovative Medicines: GlaxoSmithKline Launches Discovery Fast Track Competition for Academic Researchers. PHILADELPHIA, May 21, 2013 (BUSINESS WIRE) -- GlaxoSmithKline plc (GSK) today announced the launch of Discovery Fast Track, a competition designed to accelerate the translation of academic research into novel therapies.

Winners of the competition will partner with investigators on GSK's Discovery Partnerships with Academia (DPAc) team with a goal of developing viable research-stage drug candidates into innovative medicines. Launched in the U.K. in late 2010, the DPAc program is a new approach to drug discovery where academic partners become core members of drug-hunting teams. GSK and the academic partner share the risk and reward of innovation, where GSK funds activities in the partner laboratories, as well as provides in-kind resources to progress a program from an idea to a candidate medicine.

DPAc's reach is global. To date, GSK has initiated nine collaborations in nine disease areas, including two in the U.S. and one in Canada. The Benefits of Discovery Fast Track. Public Research for Private Gain. In a unanimous vote last month, the Regents of the University of California created a corporate entity that, if spread to all UC campuses as some regents envision, promises to further privatize scientific research produced by taxpayer-funded laboratories. The entity, named Newco for the time being, also would block a substantial amount of UC research from being accessible to the public, and could reap big profits for corporations and investors that have ties to the well-connected businesspeople who will manage it.

Despite the sweeping changes the program portends for UC, the regents' vote received virtually no press coverage. UC plans to first implement Newco at UCLA and its medical centers, but some regents, along with influential business leaders across the state, want similar entities installed at Berkeley, Davis, Santa Cruz, and other campuses. UC Regents Chairwoman Sherry Lansing called Newco at UCLA a "pilot program" for the entire UC system. In fact, that may already be the case. Clevers: 'Jonge onderzoekers hebben weinig aan topsectoren' Jonge wetenschappers met goede ideeën voor vernieuwende bedrijfjes zijn over het hoofd gezien in het beleid voor de topsectoren. “Dat is een weeffout”, vindt Hans Clevers, president van de Koninklijke Nederlandse Akademie van Wetenschappen.

Gevestigde bedrijven komen volgens Clevers maar zelden met een echte doorbraak. “Vernieuwende bedrijven als Google en Apple zijn opgezet vanuit de universiteit door een paar enthousiaste onderzoekers.” Vanmiddag praat de Tweede Kamer met VVD-minister Henk Kamp over het topsectorenbeleid, dat bedoeld is om wetenschap en bedrijfsleven beter met elkaar te laten samenwerken. Dit beleid richt zich vooral op de sterke sectoren van de Nederlandse economie en is bedoeld om innovatie aan te jagen. Maar de topsectoren lijken uiteindelijk vooral de belangen van gevestigde bedrijven te dienen, stelt Tweede Kamerlid Anne-Wil Lucas (VVD) vandaag in het Financieele Dagblad. Clevers begrijpt haar kritiek. Bovendien is er weinig keus. Patentmuur. Dat is wel eens anders geweest. Philips werd groot door intellectueel eigendom te stelen, maar nu het bedrijf zelf aan de technologische frontlinie zit zijn de rollen omgedraaid.

In de uitvindersmythologie wordt de vindingrijkheid van de enkeling geprezen, maar de saaie werkelijkheid is dat er zelden een eurekamoment is. Revolutionaire technologie ontstaat uit een proces van verbetering. Zo ook bij de gloeilamp. Patent nummer 233.898, het Edison-basisoctrooi, zou een van de meest bevochten patenten uit de geschiedenis worden. Gerard Philips, de latere oprichter van Philips, was in Londen in de zomer van 1889 en maakte het proces van Edison Electric tegen Brush van dichtbij mee.

Brush was niet alleen. Het buitenland was minder blij met dit Nederlandse ‘roofregime’. In plaats van met Brush in zee te gaan zou Philips zijn eigen fabriek beginnen. Hoe de tijden zijn veranderd. De steeds dikkere patentmuur komt niet iedereen goed uit. Corporate open source: Intellectual property and the struggle over value. I began to worry about open source when the corporate world stopped worrying and learned to love open source. For me the turning point was a drinks party in Paris in 2003, thrown by the wife of an American advertising executive temporarily based in the city.

First, a bit of context for the party and its place in the brief story I’m telling here, which is about the capture of open source by the current corporate innovation system, and the battle for the alternatives that endure. In 1998, I wasn’t at all worried about the future of Open Source Software (OSS), because clear lines were drawn between, for example, the GNU Project (Richard Stallman) and the Apache version of open source, on the one hand, and, on the other, the corporate interests that helped pass that year’s Digital Millennium Copyright Act (DMCA) and Copyright Term Extension Act.

And in fact the political defeats for open source and free software inspired new open source theory and activism. IP relativism Corporate ecosystems. BASF verkrijgt exclusieve rechten op het verhandelen van magnetocalorische materialen. Licentieovereenkomst met Nederlandse universiteiten onder auspiciën van Technologiestichting STW. BASF New Business GmbH is een overeenkomst aangegaan met de Nederlandse Technologiestichting STW, TU Delft en de Universiteit van Amsterdam om de basispatenten voor magnetocalorische materialen van de mangaan/ijzerfamilie in licentie te nemen.

Koelingssystemen op basis van deze nieuwe materialen maken een efficiëntere koeling van koelkasten en airconditioningsystemen mogelijk en zullen waarschijnlijk conventionele compressortechnologie gaan vervangen. De magnetocalorische technologie is voortgekomen uit onderzoeksprojecten die uitgevoerd zijn door professor Ekkes Brück, eerst aan de Universiteit van Amsterdam en later aan de TU Delft. STW heeft de onderzoeksprojecten gefinancierd en de resultaten gepatenteerd.

Gezamenlijke inspanningen TU Delft en BASF De partners hebben nu een belangrijke mijlpaal bereikt. STW waardeert de coöperatieve houding van alle betrokken partners. Quice® Contact. CA (Cristian) Timmermann. Resource - Patenten benadelen ontwikkelings landen. Patenten benadelen wetenschappers in de ontwikkelende landen, stelt filosoof Christian Timmermann in het proefschrift dat hij 1 november verdedigt.

Ze hinderen ontwikkelingslanden volwaardig deel te nemen aan de wetenschap. Waarom hebben patenten een negatieve invloed in ontwikkelingslanden? ‘Wereldwijd is de welvaart nu al extreem ongelijk verdeeld. Patenten drijven de prijs van innovaties op, zodat iets wat in een ontwikkeld land duur is, elders onbetaalbaar wordt. Nieuwkomers – ook in ontwikkelde landen – hebben het bovendien moeilijk omdat patenten controle geven over de ontwikkeling van nieuwe producten.’ Het deel kunnen nemen aan de wetenschap noemt u zelfs een mensenrecht.

‘Inderdaad. Waarom is wetenschap zo belangrijk voor ontwikkelingslanden? ‘Wetenschap en technologie geven onze samenleving vorm. Als we de armoede bestrijden in ontwikkelingslanden verdwijnt de kenniskloof dan niet vanzelf? Op welke manier zou er een nieuw of verbeterd systeem kunnen ontstaan? Patent Monopolies - Falkvinge. Dutch laboratory 'delaying' MERS treatment - Middle East. VPRO tegenlicht: Wat wil de EU met het zaad? Persbericht - Sterke groei patenten door Nederlandse wetenschap. Worldwide Patent Statistical Database (PATSTAT) Thomas Gurney (longgtom) sur Twitter. Drs. Leonie van Drooge: Rathenau Instituut. Leonie van Drooge (LeonievanDrooge) Dr. Edwin Horlings: Rathenau Instituut. Nu maar hopen dat het @RathenauNL... Patentaanvragen door kennisinstellingen. DUB: Meer en meer Willie Wortels bij universiteiten | Afbeelding.

UT nieuws: Universiteiten vragen vaker patent aan. Niet publiceren maar patenteren - Oude rot aan jonge hond: Shenzhen: The Silicon Valley of Hardware | Future Cities | WIRED. Shenzhen: The Maker Movement (Part 2) | Future Cities | WIRED. Shenzhen: A new breed of intellectual property (Part 3) | Future Cities | WIRED.